Journal for ImmunoTherapy of Cancer (Mar 2019)

Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1

  • Kellie N. Smith,
  • Nicolas J. Llosa,
  • Tricia R. Cottrell,
  • Nicholas Siegel,
  • Hongni Fan,
  • Prerna Suri,
  • Hok Yee Chan,
  • Haidan Guo,
  • Teniola Oke,
  • Anas H. Awan,
  • Franco Verde,
  • Ludmila Danilova,
  • Valsamo Anagnostou,
  • Ada J. Tam,
  • Brandon S. Luber,
  • Bjarne R. Bartlett,
  • Laveet K. Aulakh,
  • John-William Sidhom,
  • Qingfeng Zhu,
  • Cynthia L. Sears,
  • Leslie Cope,
  • William H. Sharfman,
  • Elizabeth D. Thompson,
  • Joanne Riemer,
  • Kristen A. Marrone,
  • Jarushka Naidoo,
  • Victor E. Velculescu,
  • Patrick M. Forde,
  • Bert Vogelstein,
  • Kenneth W. Kinzler,
  • Nickolas Papadopoulos,
  • Jennifer N. Durham,
  • Hao Wang,
  • Dung T. Le,
  • Sune Justesen,
  • Janis M. Taube,
  • Luis A. Diaz Jr,
  • Julie R. Brahmer,
  • Drew M. Pardoll,
  • Robert A. Anders,
  • Franck Housseau

DOI
https://doi.org/10.1186/s40425-019-0547-7
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 2

Abstract

Read online

.